Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 4 1Phase 1 1

Status

Unknown 3

Sponsor Class

OTHER 1006INDUSTRY 417NIH 204NETWORK 120OTHER_GOV 34UNKNOWN 3INDIV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 44Breast 32Thoracic 13Head & Neck 12Lymphoid 8CNS 4Gynecologic 3Sarcoma 2Genitourinary 2Other solid neoplasm 1Other neoplasm 1NET 1Endocrine 1

Conditions

Uterine Cervical Neoplasms 1Platinum-resistant Recurrent Ovarian Cancer 1Ovarian Neoplasms 1

Interventions

nedaplatin 1Taxes 1Carboplatin 1Albumin-Bound Paclitaxel 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × UNKNOWN × Gynecologic × Clear all
NCT04348032 2022-03-31

APPROVE

ChineseAMS

Phase 2 Unknown
152 enrolled
Gynecologic

Platinum-resistant Recurrent Ovarian Cancer

NCT04661696 2020-12-10

Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer.

ChineseAMS

Phase 2 Unknown
75 enrolled
Gynecologic

Ovarian Neoplasms

NCT01667211 2012-08-22

CSAPPPCC

ChineseAMS

Phase 2 Unknown
30 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡